il 1 β rabbit polyclonal antibodies (Abcam)
Structured Review
![Model of danger signals activation of the NALP3 inflammasome. Tissue injury leads to the formation and release of danger signals such as ATP or uric acid crystals that are recognized by the innate immune system. A number of these signals mediate a potassium efflux or other secondary intracellular danger signals that are required for NALP3 inflammasome activation [ , ]. NALP3 inflammasome then oligomerizes to recruit the adaptor ASC and caspase-1 . Activation of caspase-1 results in the processing and maturation of pro <t>IL-1</t> β into its biologically active form, active IL-1 β [ , ]. Active IL-1 β will then trigger the IL-1 β receptor, leading to the activation of multiple cytokines involved in the inflammation cascade .](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_0303/pmc04020303/pmc04020303__MI2014-370530.001.jpg)
Il 1 β Rabbit Polyclonal Antibodies, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 20241 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il+1+%CE%B2+rabbit+polyclonal+antibodies/pmc04020303-87-28-36?v=Abcam
Average 99 stars, based on 20241 article reviews
Images
1) Product Images from "Chrysophanol Inhibits NALP3 Inflammasome Activation and Ameliorates Cerebral Ischemia/Reperfusion in Mice"
Article Title: Chrysophanol Inhibits NALP3 Inflammasome Activation and Ameliorates Cerebral Ischemia/Reperfusion in Mice
Journal: Mediators of Inflammation
doi: 10.1155/2014/370530
Figure Legend Snippet: Model of danger signals activation of the NALP3 inflammasome. Tissue injury leads to the formation and release of danger signals such as ATP or uric acid crystals that are recognized by the innate immune system. A number of these signals mediate a potassium efflux or other secondary intracellular danger signals that are required for NALP3 inflammasome activation [ , ]. NALP3 inflammasome then oligomerizes to recruit the adaptor ASC and caspase-1 . Activation of caspase-1 results in the processing and maturation of pro IL-1 β into its biologically active form, active IL-1 β [ , ]. Active IL-1 β will then trigger the IL-1 β receptor, leading to the activation of multiple cytokines involved in the inflammation cascade .
Techniques Used: Activation Assay
Figure Legend Snippet: Cellular distribution of NALP3 inflammasome components and IL-1 β in the ischemic penumbra zone of cerebral cortex. Sections were triple-stained for NALP3, ASC, caspase-1 and IL-1 β (red), NeuN (green), and nucleus (blue). In tMCAO group, the neuronal karyopyknosis and chromatin margination could be observed and there was a small amount of neutrophils in marginal zone of infarction. In the normal brain (Sham), caspase-1 and NALP3 were mainly present in the nucleus of neurons whereas IL-1 β was mainly localized in the cytoplasm. ASC was present in both the nucleus and cytoplasm. After tMCAO, NALP3 and caspase-1 were redistributed predominantly to the cytoplasm, while ASC and IL-1 β location remained unchanged.
Techniques Used: Staining
Figure Legend Snippet: The dynamic expression of NALP3 inflammasome and IL-1 β during the natural inflammatory response induced by tMCAO. Western blot of dynamic expression ((a), (b), (c)). Bar graph illustrating the dynamic expression of NALP3, ASC, active caspase-1, and active IL-1 β in brain tissues (d). Bar graph illustrating dynamic expression of NALP3, ASC, caspase-1, and IL-1 β as determined by immunohistochemistry (e). Bar graph illustrating the mRNA dynamic expression of NALP3, ASC, caspase-1, and IL-1 β (f). For NALP3, ☆ P < 0.05 versus Sham, ★ P < 0.05 versus Sham, 3 h, 6 h, 12 h, 48 h, and 72 h. For ASC, △ P < 0.05 versus Sham. For active caspase-1 and active IL-1 β , ◊ P < 0.05 and □ P < 0.05 versus Sham, ◆ P < 0.05 and ■ P < 0.05 versus Sham, 3 h, 6 h, 12 h, and 72 h.
Techniques Used: Expressing, Western Blot, Immunohistochemistry
Figure Legend Snippet: Immunohistochemical staining of NALP3, ASC, caspase-1, and IL-1 β in the cerebral cortex at 24 h after ischemia (400x magnification). As compared with tMACO and Vehicle groups, the expression of NALP3, caspase-1, and IL-1 β was significantly reduced in CHR-H and CHR-M groups, but the expression of ASC remained unchanged.
Techniques Used: Immunohistochemical staining, Staining, Expressing
Figure Legend Snippet: Effect of CHR on protein expression of NALP3, ASC (a), caspase-1, active caspase-1 (b), pro IL-1 β and active IL-1 β (c). For NALP3, active caspase-1 and active IL-1 β , ★ P < 0.05, ◆ P < 0.05 and ■ P < 0.05 versus tMCAO and Vehicle (d). Bar graph of immunohistochemistry illustrating the expression of NALP3 ( ☆ P < 0.05 versus tMCAO, Vehicle and CHR-M, ★ P < 0.05 versus tMCAO, Vehicle), ASC, caspase-1 ( ◊ P < 0.05 versus tMCAO, Vehicle and CHR-M, ◆ P < 0.05 versus tMCAO, Vehicle) and IL-1 β ( ■ P < 0.05 versus tMCAO and Vehicle) (e). Bar graph illustrating CHR reduced to mRNA of NALP3, caspase-1 and IL-1 β ( ★ P < 0.05, ◆ P < 0.05 and ■ P < 0.05 versus tMCAO and Vehicle) (f).
Techniques Used: Expressing, Immunohistochemistry